2m 2m 2m 2m 2m 2m 2m
BRIDGEBIO PHARMA (BBIO)
NASDAQ
$68.02-$0.11 (-0.15%)
Price as of Oct 22, 2026 7:36 PM EDT- $13.2BMarket Cap
- 27.24%1-Year Change
- BiotechnologyIndustry
BRIDGEBIO PHARMA (BBIO)
$68.02-$0.11 (-0.15%)
Earnings Score
Valuation | BBIO | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | 0 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | BBIO | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -16.03% | ||
12-Month Momentum | 27.35% | ||
3-Month Risk Adjusted Momentum | -130.48% | ||
12-Month Risk Adjusted Momentum | 59.39% |
True Yield
Valuation | BBIO | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 1.44% | ||
Net Debt Paydown Yield | 5.02% |
Financial Health Score
Valuation | BBIO | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 5 |